Президиум РАНВестник Дальневосточного отделения Российской академии наук Vestnik of the Far East Branch of the Russian Academy of Sciences

  • ISSN (Print) 0869-7698
  • ISSN (Online) 3034-5308

Морские природные продукты: долгий путь к открытию лекарств

Код статьи
10.31857/S0869769824030011-1
DOI
10.31857/S0869769824030011
Тип публикации
Обзор
Статус публикации
Опубликовано
Авторы
Том/ Выпуск
Том / Номер выпуска 3
Страницы
12-36
Аннотация
Сотрудничество между научно-исследовательскими институтами Южной Кореи и Тихоокеанским институтом биоорганической химии имени Г.Б. Елякова (ТИБОХ) в России началось 30 лет назад, в 1993 году. С тех пор мы активно ведем исследования в области морской биотехнологии и фармацевтики. На протяжении почти 20 лет это успешное партнерство возглавлял выдающийся “дирижер” профессор Валентин Стоник, сформировавший изысканный гармоничный “оркестр”, который мы назвали KORUS MUSIC (Korea-Russia collaboration for Marine Unlimitedre Sources for Innovation and Creation). Цель данной обзорной статьи – рассказать об истории создания KORUS MUSIC и отметить значительные успехи, достигнутые в ходе наших совместных исследований, а также наметить планы нашего дальнейшего сотрудничества и совместных усилий на ближайшие 20 лет.
Ключевые слова
морские природные продукты фрондозид кукумариозид стихопозид эхинохром спинохром неопетрозид
Дата публикации
15.09.2025
Год выхода
2025
Всего подписок
0
Всего просмотров
11

Библиография

  1. 1. Banerjee P., Mandhare A., Bagalkote V. Marine natural products as source of new drugs: an updated patent review (July 2018–July 2021) // Expert Opinion on Therapeutic Patents. 2022. Vol. 32, N. 3. P. 317–363.
  2. 2. Sigwart J. D., Blasiak R., Jaspars M., Jouffray J.-B., Tasdemir D., Unlocking the potential of marine biodiscovery // Nat. Prod. Reports. 2021. Vol. 38, N. 7. P. 1235–1242.
  3. 3. Rotter A., Bacu A., Barbier M., Bertoni F., Bones A. M., Cancela, M.L., Carlsson J., Carvalho, M.F., Cegłowska M., Dalay M. C. A new network for the advancement of marine biotechnology in Europe and beyond // Front. Mar. Sci. 2020. Vol. 7. Art. 278. https://doi.org/10.3389/fmars.2020.00278.
  4. 4. Haque N., Parveen S., Tang T., Wei J., Huang Z. Marine natural products in clinical use // Mar. Drugs. 2022. Vol. 20, N. 8. Art. 528 [1–40].
  5. 5. Donia M., Hamann M. T. Marine natural products and their potential applications as anti-infective agents // Lancet Infect. Diseas. 2003. Vol. 3, N. 6. P. 338–348.
  6. 6. Jeong S. H., Kim H. K., Song I. S., Lee S. J., Ko K. S., Rhee B. D., Kim N., Mishchenko N. P., Fedoryev S. A., Stonik, V.A., Han J. Echinochrome A protects mitochondrial function in cardiomyocytes against cardiotoxic drugs // Mar. Drugs. 2014. Vol. 12, N. 5. P. 2922–2936.
  7. 7. Jeong S. H., Kim H. K., Song I. S., Noh S. J., Marquez J., Ko K. S., Rhee B. D., Kim N., Mishchenko N. P., Fedoreyev S. A., Stonik V. A., Han J. Echinochrome a increases mitochondrial mass and function by modulating mitochondrial biogenesis regulatory genes // Mar. Drugs. 2014. Vol. 12, N. 8. P. 4602–4615.
  8. 8. Lee S. R., Pronto J. R., Sarankhuu B. E., Ko K. S., Rhee B. D., Kim N., Mishchenko N. P., Fedoreyev S. A., Stonik V. A., Han J. Acetylcholinesterase inhibitory activity of pigment echinochrome A from sea urchin Scaphechinus mirabilis // Mar. Drugs. 2014. Vol. 12, N. 6. P. 3560–3573.
  9. 9. Kim H. K., Youm J. B., Jeong S. H., Lee S. R., Song I. S., Ko T. H., Pronto J. R., Ko K. S., Rhee B. D., Kim N., Nilius B., Mischchenko N. P., Fedoreyev S. A., Stonik V. A., Han J. Echinochrome A regulates phosphorylation of phospholamban Ser16 and Thr17 suppressing cardiac SERCA2A Ca²⁺ reuptake // Pflugers Arch. 2015. Vol. 467, N. 10. P. 2151–2163.
  10. 10. Shubina L. K., Makarieva T. N., Yashunsky D. V., Nifantiev N. E., Denisenko V. A., Dmitrenok, P.S., Dyshlovoy S. A., Fedorov S. N., Krasokhin V. B., Jeong S. H., Han J., Stonik V. A. Pyridine nucleosides neopetrosides A and B from a marine Neopetrosia sp. sponge. Synthesis of neopetroside A and its β-riboside fnalogue // J. Nat. Prod. 2015. Vol. 78, N. 6. P. 1383–1389.
  11. 11. Seo D. Y., McGregor R.A., Noh S. J., Choi S. J., Mishchenko N. P., Fedoreyev S. A., Stonik V. A., Han J. Echinochrome A improves exercise capacity during short-term endurance training in rats // Mar. Drugs. 2015. Vol. 13, N. 9. P. 5722–5731.
  12. 12. Yoon C. S., Kim H. K., Mishchenko N. P., Vasileva E. A., Fedoreyev, S.A., Stonik V. A., Han J. Spinochrome D attenuates doxorubicin-induced cardiomyocyte death via improving glutathione metabolism and attenuating oxidative stress // Mar. Drugs. 2018. Vol. 17, N. 1. Art. 2 [1–20].
  13. 13. Kim H. K., Cho S. W., Heo H. J., Jeong S. H., Kim M., Ko K. S., Rhee B. D., Mishchenko N. P., Vasileva E. A., Fedoreyev S. A., Stonik V. A., Han J. A novel atypical PKC-Iota inhibitor, echinochrome A, enhances cardiomyocyte differentiation from mouse embryonic stem cells // Mar. Drugs. 2018. Vol. 16, No. 6. Art. 192 [1–14].
  14. 14. Yoon C. S., Kim H. K., Mishchenko N. P., Vasileva E. A., Fedoreyev S. A., Shestak O. P., Balaneva N. N., Novikov V. L., Stonik V. A., Han J. The protective effects of echinochrome A structural analogs against oxiative stress and doxorubicin in AC16 cardiomyocytes // Mol. Cell. Toxicol. 2019. Vol. 15. P. 407–414.
  15. 15. Park J. H., Lee N. K., Lim H. J., Mazumder S., Rethineswaran K. V., Kim Y. J., Jang, W. B.; Ji S. T., Kang S., Kim D. Y., Van L. T.H., Giang L. T.T., Kim D. H., Ha J. S., Yun J., Kim H., Han J., Mishchenko N. P., Fedoreyev S. A., Vasileva E. A., Kwon S. M., Baek S. H. Therapeutic cell protective role of histochrome under oxidative stress in human cardiac progenitor cells // Mar. Drugs. 2019. Vol. 17, N. 6. Art. 368 [1–15].
  16. 16. Kim R., Hur D., Kim H. K., Han J., Mishchenko N. P., Fedoreyev S. A., Stonik V. A., Chang W. Echinochrome A attenuates cerebral ischemic injury through regulation of cell survival after middle cerebral artery occlusion in rat // Mar. Drugs. 2019. Vol. 17, N. 9. Art. 501 [1–8].
  17. 17. Oh S. J., Seo Y., Ahn J. S., Shin Y. Y., Yang J. W., Kim H. K., Han J., Mishchenko N. P., Fedoreyev S. A., Stonik V. A., Kim H. S. Echinochrome A reduces colitis in mice and induces in vitro generation of regulatory immune cells // Mar. Drugs. 2019. Vol. 17. N. 11. Art. 622 [1–10].
  18. 18. Park G. B., Kim M. J., Vasileva E. A., Mishchenko N. P., Fedoreyev S. A., Stonik V. A., Han J., Lee H. S., Kim D., Jeong J. Y. Echinochrome A promotes ex vivo expansion of peripheral blood-derived CD34(+) cells, potentially through downregulation of ROS production and activation of the Src-Lyn-p110δ pathway // Mar. Drugs. 2019. Vol. 17, N. 9. Art. 526 [1–14].
  19. 19. Kim J. M., Kim J. H., Shin S. C., Park G. C., Kim H. S., Kim K., Kim H. K., Han J., Mishchenko N. P., Vasileva E. A., Fedoreyev S. A., Stonik V. A., Lee B. J. The protective effect of echinochrome A on extracellular matrix of vocal folds in ovariectomized rats // Mar. Drugs. 2020. Vol. 18, N. 2. Art. 77 [1–15].
  20. 20. Yun H. R., Ahn S. W., Seol B., Vasileva E. A., Mishchenko N. P., Fedoreyev S. A., Stonik V. A., Han J., Ko K. S., Rhee B. D., Seol J. E., Kim H. K. Echinochrome A treatment alleviates atopic dermatitis-like skin lesions in NC/Nga mice via IL-4 and IL-13 suppression // Mar. Drugs. 2021. V. 19, N. 11 Art. 622 [1–11].
  21. 21. Seol J. E., Ahn S. W., Seol B., Yun H. R., Park N., Kim H. K., Vasileva E. A., Mishchenko N. P., Fedoreyev S. A., Stonik V. A., Han J. Echinochrome A protects against ultraviolet B-induced photoaging by lowering collagen degradation and inflammatory cell infiltration in hairless mice // Mar. Drugs. 2021. Vol. 19, N. 10. Art. 550 [1–13].
  22. 22. Park G. T., Yoon J. W., Yoo S. B., Song Y. C., Song P., Kim H. K., Han J., Bae S. J., Ha K. T., Mishchenko N. P., Fedoreyev S. A., Stonik V. A., Kim M. B., Kim J. H. Echinochrome A treatment alleviates fibrosis and inflammation in bleomycin-induced scleroderma // Mar. Drugs. 2021. Vol. 19, N. 5. Art. 237 [1–11].
  23. 23. Kim H. K., Vasileva E. A., Mishchenko N. P., Fedoreyev S. A., Han J., Multifaceted clinical effects of echinochrome // Mar. Drugs. 2021. Vol. 19, N. 8. Art. 412 [1–16].
  24. 24. Song B. W., Kim S., Kim R., Jeong S., Moon H., Kim H., Vasileva E. A., Mishchenko N. P., Fedoreyev S. A., Stonik V. A., Lee M. Y., Kim J., Kim H. K., Han J., Chang W. Regulation of inflammation-mediated endothelial to mesenchymal transition with echinochrome A for improving myocardial dysfunction // Mar. Drugs. 2022. Vol. 20, N. 12. Art. 756 [1–17].
  25. 25. Choi M. R., Lee H., Kim H. K., Han J., Seol J. E., Vasileva E. A., Mishchenko N. P., Fedoreyev S. A., Stonik V. A., Ju W. S., Kim D. J., Lee S. R., Echinochrome A inhibits melanogenesis in B16F10 cells by downregulating CREB signaling // Mar. Drugs. 2022. Vol. 20, N. 9. Art. 555 [1–12].
  26. 26. Ahn J. S., Shin Y. Y., Oh S. J., Song M. H., Kang M. J., Park S. Y., Nguyen P. T., Nguyen, D. K., Kim H. K., Han J., Vasileva E. A., Mishchenko N. P., Fedoreyev S. A., Stonik V. A., Seo Y., Lee B. C., Kim H. S. Implication of echinochrome A in the plasticity and damage of intestinal epithelium // Mar Drugs. 2022, No. 20, N. 11. Art. 715 [1–14].
  27. 27. Kim J. M., Shin S. C., Cheon Y. I., Kim H. S., Park G. C., Kim H. K., Han J., Seol J. E., Vasileva E. A., Mishchenko N. P., Fedoreyev S. A., Stonik V. A., Lee B. J., Effect of echinochrome A on submandibular gland dysfunction in ovariectomized rats // Mar. Drugs. 2022. Vol. 20, N. 12. Art. 729 [1–14].
  28. 28. Tang X., Nishimura A., Ariyoshi K., Nishiyama K., Kato Y., Vasileva E. A., Mishchenko N. P., Fedoreyev S. A., Stonik V. A., Kim H. K., Han J., Kanda Y., Umezawa K., Urano Y., Akaike T., Nishida M. Echinochrome prevents sulfide catabolism-associated chronic heart failure after myocardial infarction in mice // Mar. Drugs. 2023. Vol. 21, N. 1. Art. 52 [1–17].
  29. 29. Han D. G., Kwak J., Choi E., Seo S. W., Vasileva E. A., Mishchenko N. P., Fedoreyev S. A., Stonik V. A., Kim H. K., Han J., Byun J. H., Jung I. H., Yun H., Yoon I. S. Physicochemical characterization and phase II metabolic profiling of echinochrome A, a bioactive constituent from sea urchin, and its physiologically based pharmacokinetic modeling in rats and humans // Biomed. Pharmacother. 2023. Vol. 162. Art. 114589 [1–16].
  30. 30. Kim S. E., Chung E. D.S., Vasileva E. A., Mishchenko N. P., Fedoreyev S. A., Stonik V. A., Kim H. K., Nam J. H., Kim S. J. Multiple effects of echinochrome A on selected ion channels implicated in skin physiology // Mar. Drugs. 2023. Vol. 21, No. 2. Art. 78 [1–16]
  31. 31. Pham T. K., Nguyen T. H.T., Yun H. R., Vasileva E. A., Mishchenko N. P., Fedoreyev S. A., Stonik V. A., Vu T. T., Nguyen H. Q., Cho S. W., Kim H. K., Han J. Echinochrome A prevents diabetic nephropathy by inhibiting the PKC-iota pathway and enhancing renal mitochondrial function in db/db mice // Mar. Drugs. 2023. Vol. 21, N. 4. Art. 222 [1–15].
  32. 32. Jin J. O., Shastina V. V., Shin S. W., Xu Q., Park J. I., Rasskazov V. A., Avilov S. A., Fedorov, S.N., Stonik V. A., Kwak J. Y., Differential effects of triterpene glycosides, frondoside A and cucumarioside A2-2 isolated from sea cucumbers on caspase activation and apoptosis of human leukemia cells // FEBS Lett. 2009. Vol. 583, N. 4. P. 697–702.
  33. 33. Park J. I., Bae H. R., Kim C. G., Stonik V. A., Kwak J. Y., Relationships between chemical structures and functions of triterpene glycosides isolated from sea cucumbers // Front. Chem. 2014. Vol. 2. Art. 77 [1–14].
  34. 34. Yun S. H., Park E. S., Shin, S.W., Na Y. W., Han J. Y., Jeong J. S., Shastina V. V., Stonik V. A., Park J. I., Kwak J. Y. Stichoposide C induces apoptosis through the generation of ceramide in leukemia and colorectal cancer cells and shows in vivo antitumor activity // Clin. Cancer Res. 2012. Vol. 18, N. 21. P. 5934–5948.
  35. 35. Yun S. H., Park E. S., Shin S. W., Ju M. H.; Han, J.Y., Jeong J. S., Kim S. H., Stonik V. A., Kwak J. Y., Park J. I. By activating Fas/ceramide synthase 6/p38 kinase in lipid rafts, stichoposide D inhibits growth of leukemia xenografts // Oncotarget. 2015. Vol. 6, N. 29. P. 27596–27612.
  36. 36. Yun S. H., Sim E. H., Han S. H., Kim T. R., Ju M. H., Han J. Y., Jeong J. S., Kim S. H., Silchenko A. S., Stonik V. A., Park J. I. In vitro and in vivo anti-leukemic effects of cladoloside C2 are mediated by activation of Fas/ceramide synthase 6/p38 kinase/c-Jun NH2-terminal kinase/caspase-8 // Oncotarget. 2018 Vol. 9, N. 1. P. 495–511.
  37. 37. Cui H., Liu J., Vasileva E. A., Mishchenko N. P., Fedoreyev S. A., Stonik V. A., Zhang, Y., Echinochrome A reverses kidney abnormality and reduces blood pressure in a rat model of preeclampsia // Mar. Drugs. 2022. Vol. 20, N. 11. Art. 722 [1–13].
  38. 38. Daniotti S., Re I. Marine biotechnology: challenges and development market trends for the enhancement of biotic resources in industrial pharmaceutical and food applications. A statistical analysis of scientific literature and business models // Mar. Drugs. 2021. Vol. 19. N. 2. Art. 61 [1–35].
  39. 39. Lindequist U. Marine-derived pharmaceuticals–challenges and opportunities // Biomol. Ther. 2016. Vol. 24, N. 6. 561–571.
  40. 40. OECD, Marine Biotechnology and the Bioeconomy. Paris: OECD, 2012.
QR
Перевести

Индексирование

Scopus

Scopus

Scopus

Crossref

Scopus

Высшая аттестационная комиссия

При Министерстве образования и науки Российской Федерации

Scopus

Научная электронная библиотека